At high concentrations (612 μM), 56 induced cell death in K‐RAS‐mutant HCT116 colorectal cancer cells (CRC) when combined with cetuximab (25 μg/ml), a monoclonal antibody against epidermal growth factor receptor (EGFR). This evidence concerns the gene KRAS and colorectal carcinoma.